2-methyl-5-nitro-N-(quinolin-8-yl)benzenesulfonamide

ID: ALA429586

Cas Number: 353515-11-4

PubChem CID: 5237741

Max Phase: Preclinical

Molecular Formula: C16H13N3O4S

Molecular Weight: 343.36

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)Nc1cccc2cccnc12

Standard InChI:  InChI=1S/C16H13N3O4S/c1-11-7-8-13(19(20)21)10-15(11)24(22,23)18-14-6-2-4-12-5-3-9-17-16(12)14/h2-10,18H,1H3

Standard InChI Key:  VTMJBTAZUZNDBS-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -5.3372  -15.1489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3372  -15.9753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6255  -16.3862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6255  -14.7334    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9092  -15.1489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9127  -15.9753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2028  -16.3892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4849  -15.9814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1958  -14.7365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4839  -15.1564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4703  -13.5061    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1922  -13.9122    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7584  -13.9260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7715  -14.7517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0669  -15.1735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3447  -14.7744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3316  -13.9487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0406  -13.5223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0683  -12.7930    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8901  -12.7930    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0287  -12.7005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0812  -15.9970    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3767  -16.4202    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7999  -16.3956    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  9 12  1  0
 13 11  1  0
 11 12  1  0
 13 14  1  0
  1  2  1  0
  1  4  2  0
  2  3  2  0
  5  9  2  0
  6  7  2  0
  7  8  1  0
 13 18  2  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
  8 10  2  0
 11 19  2  0
  9 10  1  0
 11 20  2  0
  3  6  1  0
 18 21  1  0
  5  4  1  0
  5  6  1  0
 22 23  2  0
 22 24  1  0
 15 22  1  0
M  CHG  2  22   1  24  -1
M  END

Alternative Forms

Associated Targets(Human)

NFKBIA Tchem NF-kappaB inhibitor alpha (187 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RELA Tchem Nuclear factor NF-kappa-B p65 subunit (627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 343.36Molecular Weight (Monoisotopic): 343.0627AlogP: 3.25#Rotatable Bonds: 4
Polar Surface Area: 102.20Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 6.72CX Basic pKa: 3.68CX LogP: 3.07CX LogD: 2.50
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.58Np Likeness Score: -2.13

References

1. Xie Y, Deng S, Thomas CJ, Liu Y, Zhang YQ, Rinderspacher A, Huang W, Gong G, Wyler M, Cayanis E, Aulner N, Többen U, Chung C, Pampou S, Southall N, Vidović D, Schürer S, Branden L, Davis RE, Staudt LM, Inglese J, Austin CP, Landry DW, Smith DH, Auld DS..  (2008)  Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation.,  18  (1): [PMID:18024113] [10.1016/j.bmcl.2007.10.100]
2. Tsai KC, Teng LW, Shao YM, Chen YC, Lee YC, Li M, Hsiao NW..  (2009)  The first pharmacophore model for potent NF-kappaB inhibitors.,  19  (19): [PMID:19726185] [10.1016/j.bmcl.2009.08.021]

Source